![](/img/cover-not-exists.png)
A proof-of-concept, randomized, placebo-controlled, multiple cross-overs (n-of-1) study of naftazone in Parkinson’s disease
Olivier Rascol, Joaquim Ferreira, Laurence Nègre-Pages, Santiago Perez-Lloret, Lucette Lacomblez, Monique Galitzky, Jean-Christophe Lemarié, Jean-Christophe Corvol, Jonathan M. Brotchie, Laura BossiVolume:
26
Year:
2012
Language:
english
Pages:
1
DOI:
10.1111/j.1472-8206.2011.00951.x
File:
PDF, 163 KB
english, 2012